Protalix BioTherapeutics, Inc.

AMEX:PLX

Biotechnology

Healthcare
$3.02 +4.21%

+$0.09 today

Market cap
$254.64M
Beta
0.01
P/E (TTM)
11.0
EPS (TTM)
$0.19
52W Low $1.32High $3.19

Volume 0.96M

Average 0.81M

Price history

Protalix BioTherapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+70.62%

Period high

$3.15

Period low

$1.67

Latest

$3.02

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 10, 2026Nov 10, 2026
8-KNov 10, 2026Nov 10, 2026
SC 13GOct 15, 2026Oct 15, 2026
4Sep 9, 2026Sep 9, 2026
4Sep 4, 2026Sep 4, 2026
4Sep 4, 2026Sep 4, 2026
4Sep 4, 2026Sep 4, 2026
4Sep 4, 2026Sep 4, 2026
4Sep 4, 2026Sep 4, 2026
4Sep 4, 2026Sep 4, 2026
4Sep 4, 2026Sep 4, 2026
4Sep 4, 2026Sep 4, 2026
8-KAug 12, 2026Aug 12, 2026
10-QAug 12, 2026Aug 12, 2026
S-8Aug 12, 2026Aug 12, 2026

Competitors

Who does Protalix BioTherapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about PLX's filings, answered from its disclosures.

What is the latest PLX filing?

The latest filing shown is 10-Q dated Nov 10, 2026.

How many recent filings does PLX have?

Intrinsic Alpha currently shows 20 recent filings for PLX.